PremiumIONS

We identified an unusual rating upgrade for Ionis: UBS upgrades to buy and doubles price target to $88

The upgrade comes after a significant insider stock purchase by a senior director, and focuses on the potential of the company's drugs.

By the SpyStocks desk · · 1h ago · 3 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Sign in to keep readingJoin the channel

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Good intel travels.

Share this story

Other Stories

Strange gap in Praxis stock: target of $1,201 for a stock trading at $240

AnalystsPRAX4d ago3 min read

Fluence: surprising insider purchases after stock plunge

PremiumInsidersFLNC6d ago2 min read

Sector climbs following a report

PremiumBreaking13m ago1 min read